1. Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes
   Ronja S. Adam et al, 2022, Molecular Oncology CrossRef
2. A Novel Identified Long Non-coding RNA, lncRNA MEF2C-AS1, Inhibits Cervical Cancer via Regulation of miR-592/RSPO1
   Xiaoping Wang et al, 2021, Frontiers in Molecular Biosciences CrossRef
3. Increased Expression of miR-7a-5p and miR-592 during Expansion of Rat Dental Pulp Stem Cells and Their Implication in Osteogenic Differentiation
   Weiqiong Rong et al, 2022, Cells Tissues Organs CrossRef
4. Identifying a miRNA signature for predicting the stage of breast cancer
   Srinivasulu Yerukala Sathipati et al, 2018, Scientific Reports CrossRef
5. Immunotherapy for lung cancer combining the oligodeoxynucleotides of TLR9 agonist and TGF-β2 inhibitor
   Yunpeng Yao et al, 2023, Cancer Immunology, Immunotherapy CrossRef
6. MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification
   Peng Lei et al, 2022, Bioengineered CrossRef
7. Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review
   Verónica Gómez-Gil, 2021, Cancers CrossRef
8. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression
   Joanna Patrycja Wróblewska et al, 2020, Genes CrossRef
9. Somatic Mutations in miRNA Genes in Lung Cancer—Potential Functional Consequences of Non-Coding Sequence Variants
   Paulina Galka-Marciniak et al, 2019, Cancers CrossRef